Relationship of the reductive metabolism of indicine N-oxide to its antitumor activity
Powis, G.; Ames, M.M.; Kovach, J.S.
Research Communications in Chemical Pathology and Pharmacology 24(3): 559-569
1979
ISSN/ISBN: 0034-5164 PMID: 451340 Document Number: 143590
Several pyrrolizidine alkaloids have been demonstrated to have antitumor activity in experimental tumor systems. In general the free base form of the alkaloid exhibits greater biological activity than the corresponding N-oxide and the N-oxide must be metabolized to the base for the subsequent formation of alkylating intermediates. Indicine N-oxide is an exception in that it is a more active antitumor agent than its free base indicine. Studies of the antitumor activity and metabolism of indicine N-oxide, and the closely related compound, heliotrine N-oxide, given orally and intraperitoneally to mice bearing P-388 leukemia, suggest that conversion of indicine N-oxide to indicine is not essential for its antitumor activity.